The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

被引:0
作者
C. J. Currie
C. D. Poole
E. A. M. Gale
机构
[1] Cardiff University,School of Medicine
[2] The Pharma Research Centre,Department of Epidemiology
[3] Cardiff MediCentre,Diabetes and Metabolism, School of Medicine
[4] Pharmatelligence,undefined
[5] Bristol University,undefined
来源
Diabetologia | 2009年 / 52卷
关键词
Cancer; Insulin; Insulin analogues; Metformin; Sulfonylureas; Survival; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1766 / 1777
页数:11
相关论文
共 83 条
[1]  
Coughlin SS(2004)Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults Am J Epidemiol 159 1160-1167
[2]  
Giovannucci E(2007)The role of obesity and related metabolic disturbances in cancers of the colon, prostate and pancreas Gastroenterology 132 2208-2225
[3]  
Michaud D(2007)The role of the IGF system in cancer growth and metastasis: overview and recent insights Endocr Rev 28 20-47
[4]  
Samami AA(2004)Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients Gastroenterology 127 1044-1050
[5]  
Yakar S(2005)Metformin and reduced risk of cancer in diabetic patients BMJ 330 1304-1305
[6]  
LeRoith D(2006)Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 254-258
[7]  
Brodt D(2000)Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use Diabetes 49 999-1005
[8]  
Yang Y-X(2009)Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines Endocr Relat Cancer 16 429-441
[9]  
Hennessy S(2004)Diabetes mellitus and risk of prostate cancer: a meta-analysis Diabetologia 47 1071-1078
[10]  
Lewis JD(1991)Validation of information recorded on general practitioner based computerized data resource in the United Kingdom BMJ 302 766-768